Julie E Bauman, MD, MPH
The University of Arizona · University of Pittsburgh
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Julie E Bauman, MD, MPH as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:45 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT03422536 · Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell CarcinomaUniversity of Arizona · completed · Head and Neck Basaloid Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Oropharyngeal Squamous Cell Carcinoma · principal investigator
- Early Ph1NCT03182959 · Broccoli Sprout Extract in Preventing Recurrence in Patients With Tobacco-Related Head and Neck Squamous Cell CancerUniversity of Arizona · completed · HNSCC, Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma · principal investigator
- Ph1/Ph2NCT02298595 · Cetuximab, Cisplatin and BYL719 for HPV-Associated Oropharyngeal Squamous Cell CarcinomaJulie E. Bauman, MD, MPH · withdrawn · Carcinoma, Squamous, Squamous Cell Carcinoma, Oropharyngeal Neoplasms · principal investigator
- Ph1NCT02277184 · Ficlatuzumab, Cisplatin and IMRT in Locally Advanced Head and Neck Squamous Cell CarcinomaJulie E. Bauman, MD, MPH · terminated · Carcinoma, Squamous Cell of Head and Neck · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:45 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Cancer Biology Program (CBP)P30CA023074 · NCI · UNIVERSITY OF ARIZONA · PI Koenraad Van Doorslaer · fiscal years 2012 to 2026Named on NCT03422536
- Head and Neck Cancer SPOREP50CA097190 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Heath Devin Skinner, Jose P. Zevallos · fiscal years 2012 to 2026Named on NCT03182959
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.